bioTheranostics Introduces PRECIS Precision Medicine
bioTheranostics Inc introduces a new product line of high medical value biomarkers for response, resistance, and pathway interrogation called PRECIS Precision Medicine.
Read MoreSearch Results for: lung cancer
QIAGEN Announces Agreements with Two Biotech Companies
QIAGEN has come to agreements with two US biotech companies to acquire worldwide exclusive rights to biomarkers that are expected to play an important role in personalized treatment of various cancers.
Read MoreResults From Tissue of Origin Test to be Presented at AACR-IASLC Conference
Results from a study involving Pathwork Diagnostics Inc’s Tissue of Origin Test will be presented at the AACR-IASLC Joint Conference.
Read More
Testing/Diagnostics
ARUP LaboratoriesBiohit IncBioneer IncMitsubishi Chemical Medience CorpSiemens Healthcare DiagnosticsHoefer IncAbbottArlington Scientific IncEraGen Biosciences
Read MoreStudy: US Lung Cancer Rates Decline
The rates of new lung cancer cases in the US dropped among men in 35 states and among women in 6 states between 1999 and 2008.
Read More